Pathogenesis of HIV in the Central Nervous System

Overview

Journal Curr HIV/AIDS Rep

Publisher Current Science

Specialty Infectious Diseases

Date 2010 Dec 31

PMID 21191673

Citations 120

Authors

Victor Valcour

Pasiri Sithinamsuwan

Scott Letendre

Beau Ances

Affiliations

Soon will be listed here.

Abstract

HIV can infect the brain and impair central nervous system (CNS) function. Combination antiretroviral therapy (cART) has not eradicated CNS complications. HIV-associated neurocognitive disorders (HAND) remain common despite cART, although attenuated in severity. This may result from a combination of factors including inadequate treatment of HIV reservoirs such as circulating monocytes and glia, decreased effectiveness of cART in CNS, concurrent illnesses, stimulant use, and factors associated with prescribed drugs, including antiretrovirals. This review highlights recent investigations of HIV-related CNS injury with emphasis on cART-era neuropathological mechanisms in the context of both US and international settings.

Citing Articles

A Comprehensive Review on Utilizing Human Brain Organoids to Study Neuroinflammation in Neurological Disorders.

Rubio A, Hamilton L, Bausch M, Jin M, Papetti A, Jiang P J Neuroimmune Pharmacol. 2025; 20(1):23.

PMID: 39987404 PMC: 11846768. DOI: 10.1007/s11481-025-10181-x.

Influence of plasma exosomes from women living with HIV Stratified by HAND on monocyte subpopulations from healthy women without HIV.

Collazo B, Ortiz-Valentin L, Negron-Rodriguez C, Medina-Colon J, Cantres-Rosario Y, Rodriguez E J Neurovirol. 2025; .

PMID: 39885101 DOI: 10.1007/s13365-024-01240-9.

Cannabis Use and Cannabidiol Modulate HIV-Induced Alterations in TREM2 Expression: Implications for Age-Related Neuropathogenesis.

Avalos B, Kulbe J, Ford M, Laird A, Walter K, Mante M Viruses. 2024; 16(10.

PMID: 39459844 PMC: 11512329. DOI: 10.3390/v16101509.

Emotional Loneliness Is Related to Objective Cognitive Function in Older People With HIV in the Washington-Baltimore Area: A Cross-sectional Study.

Yoo-Jeong M, Dastgheyb R, Shorer E, Demsky C, Fox O, Inaganti D J Assoc Nurses AIDS Care. 2024; 35(6):519-529.

PMID: 39145637 PMC: 11527567. DOI: 10.1097/JNC.0000000000000491.

HIV and COVID-19: two pandemics with significant (but different) central nervous system complications.

Magaki S, Zhang T, Han K, Hilda M, Yong W, Achim C Free Neuropathol. 2024; 5.

PMID: 38469363 PMC: 10925920. DOI: 10.17879/freeneuropathology-2024-5343.

References

Sacktor N, Nakasujja N, Skolasky R, Rezapour M, Robertson K, Musisi S . HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis. 2009; 49(5):780-6. PMC: 2941149. DOI: 10.1086/605284. View

Sacktor N, Nakasujja N, Robertson K, Clifford D . HIV-associated cognitive impairment in sub-Saharan Africa--the potential effect of clade diversity. Nat Clin Pract Neurol. 2007; 3(8):436-43. DOI: 10.1038/ncpneuro0559. View

Anthony I, Ramage S, Carnie F, Simmonds P, Bell J . Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol. 2006; 111(6):529-38. DOI: 10.1007/s00401-006-0037-0. View

Vivithanaporn P, Heo G, Gamble J, Krentz H, Hoke A, Gill M . Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology. 2010; 75(13):1150-8. PMC: 3013488. DOI: 10.1212/WNL.0b013e3181f4d5bb. View

Mishra M, Vetrivel S, Siddappa N, Ranga U, Seth P . Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Ann Neurol. 2007; 63(3):366-76. DOI: 10.1002/ana.21292. View

Dewey J, Hana G, Russell T, Price J, McCaffrey D, Harezlak J . Reliability and validity of MRI-based automated volumetry software relative to auto-assisted manual measurement of subcortical structures in HIV-infected patients from a multisite study. Neuroimage. 2010; 51(4):1334-44. PMC: 2884380. DOI: 10.1016/j.neuroimage.2010.03.033. View

Clifford D, Smurzynski M, Park L, Yeh T, Zhao Y, Blair L . Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology. 2009; 73(4):309-14. PMC: 2715213. DOI: 10.1212/WNL.0b013e3181af7a10. View

Liu Y, Tang X, McArthur J, Scott J, Gartner S . Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol. 2000; 6 Suppl 1:S70-81. View

Ances B, Roc A, Korczykowski M, Wolf R, Kolson D . Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients. J Neurovirol. 2008; 14(5):418-24. PMC: 2819068. DOI: 10.1080/13550280802298112. View

10.

Valcour V, Sacktor N, Paul R, Watters M, Selnes O, Shiramizu B . Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort. J Acquir Immune Defic Syndr. 2006; 43(4):405-10. DOI: 10.1097/01.qai.0000243119.67529.f5. View

11.

Clifford D . HIV-associated neurocognitive disease continues in the antiretroviral era. Top HIV Med. 2008; 16(2):94-8. View

12.

Marra C, Zhao Y, Clifford D, Letendre S, Evans S, Henry K . Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. 2009; 23(11):1359-66. PMC: 2706549. DOI: 10.1097/QAD.0b013e32832c4152. View

13.

Valcour V, Shiramizu B, Shikuma C . HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications. J Leukoc Biol. 2010; 87(4):621-6. PMC: 2858306. DOI: 10.1189/jlb.0809571. View

14.

Joska J, Fincham D, Stein D, Paul R, Seedat S . Clinical correlates of HIV-associated neurocognitive disorders in South Africa. AIDS Behav. 2009; 14(2):371-8. DOI: 10.1007/s10461-009-9538-x. View

15.

Schifitto G, Navia B, Yiannoutsos C, Marra C, Chang L, Ernst T . Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS. 2007; 21(14):1877-86. DOI: 10.1097/QAD.0b013e32813384e8. View

16.

Antinori A, Arendt G, Becker J, Brew B, Byrd D, Cherner M . Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007; 69(18):1789-99. PMC: 4472366. DOI: 10.1212/01.WNL.0000287431.88658.8b. View

17.

Gisslen M, Hagberg L, Brew B, Cinque P, Price R, Rosengren L . Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis. 2007; 195(12):1774-8. DOI: 10.1086/518043. View

18.

Hoare J, Fouche J, Spottiswoode B, Joska J, Schoeman R, Stein D . White matter correlates of apathy in HIV-positive subjects: a diffusion tensor imaging study. J Neuropsychiatry Clin Neurosci. 2010; 22(3):313-20. DOI: 10.1176/jnp.2010.22.3.313. View

19.

Nowacek A, Gendelman H . NanoART, neuroAIDS and CNS drug delivery. Nanomedicine (Lond). 2009; 4(5):557-74. PMC: 2746674. DOI: 10.2217/nnm.09.38. View

20.

Seeley W, Crawford R, Zhou J, Miller B, Greicius M . Neurodegenerative diseases target large-scale human brain networks. Neuron. 2009; 62(1):42-52. PMC: 2691647. DOI: 10.1016/j.neuron.2009.03.024. View